Katherine E. Keating

2.2k total citations
22 papers, 1.3k citations indexed

About

Katherine E. Keating is a scholar working on Molecular Biology, Oncology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Katherine E. Keating has authored 22 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Katherine E. Keating's work include Ion channel regulation and function (7 papers), DNA Repair Mechanisms (6 papers) and Cancer-related Molecular Pathways (5 papers). Katherine E. Keating is often cited by papers focused on Ion channel regulation and function (7 papers), DNA Repair Mechanisms (6 papers) and Cancer-related Molecular Pathways (5 papers). Katherine E. Keating collaborates with scholars based in United Kingdom, Ireland and Australia. Katherine E. Keating's co-authors include Martin F. Lavin, Sergei Kozlov, Tommie V. McCarthy, Kathleen A. Quane, Bernadette M. Manning, Kum Kum Khanna, Susan P. Lees‐Miller, Doug W. Chan, Karen Hobson and Brian Gabrielli and has published in prestigious journals such as Journal of Biological Chemistry, Nature Genetics and Journal of Clinical Oncology.

In The Last Decade

Katherine E. Keating

22 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katherine E. Keating United Kingdom 13 1.1k 407 400 239 157 22 1.3k
Roy A. Lynch United States 12 1.1k 1.0× 718 1.8× 192 0.5× 113 0.5× 83 0.5× 16 1.9k
Heinz Hoschuetzky Germany 7 1.3k 1.2× 112 0.3× 197 0.5× 61 0.3× 106 0.7× 7 1.6k
Mariko Nishiyama Japan 15 439 0.4× 87 0.2× 182 0.5× 81 0.3× 79 0.5× 36 804
Shelli M. Morris United States 13 868 0.8× 89 0.2× 165 0.4× 152 0.6× 72 0.5× 22 1.3k
Ayush Dagvadorj United States 19 672 0.6× 104 0.3× 448 1.1× 206 0.9× 60 0.4× 23 1.2k
Husna Abedi United Kingdom 9 805 0.7× 94 0.2× 165 0.4× 219 0.9× 80 0.5× 9 1.1k
Angela Russo United States 20 537 0.5× 58 0.1× 142 0.4× 141 0.6× 45 0.3× 38 1.0k
Dillon Phan United States 12 792 0.7× 145 0.4× 158 0.4× 143 0.6× 77 0.5× 16 1.0k
Mark Shilkrut United States 16 648 0.6× 173 0.4× 378 0.9× 96 0.4× 129 0.8× 45 1.3k
Raudel Sandoval United States 13 504 0.5× 105 0.3× 137 0.3× 116 0.5× 73 0.5× 15 1.0k

Countries citing papers authored by Katherine E. Keating

Since Specialization
Citations

This map shows the geographic impact of Katherine E. Keating's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katherine E. Keating with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katherine E. Keating more than expected).

Fields of papers citing papers by Katherine E. Keating

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katherine E. Keating. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katherine E. Keating. The network helps show where Katherine E. Keating may publish in the future.

Co-authorship network of co-authors of Katherine E. Keating

This figure shows the co-authorship network connecting the top 25 collaborators of Katherine E. Keating. A scholar is included among the top collaborators of Katherine E. Keating based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katherine E. Keating. Katherine E. Keating is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hofman, Paul, Petros Christopoulos, Nicky D’Haene, et al.. (2025). Proposal of real-world solutions for the implementation of predictive biomarker testing in patients with operable non-small cell lung cancer. Lung Cancer. 201. 108107–108107. 1 indexed citations
2.
Malerba, Natascia, et al.. (2018). A NGS-Targeted Autism/ID Panel Reveals Compound Heterozygous GNB5 Variants in a Novel Patient. Frontiers in Genetics. 9. 626–626. 9 indexed citations
3.
Foster, Joseph, Assa Oumie, Fiona S. Togneri, et al.. (2015). Cross-laboratory validation of the OncoScan® FFPE Assay, a multiplex tool for whole genome tumour profiling. BMC Medical Genomics. 8(1). 5–5. 71 indexed citations
4.
Huang, Shuguang, Dakun Wang, Tianhua Wang, et al.. (2015). Analytical Performance of a 15-Gene Prognostic Assay for Early-Stage Non–Small-Cell Lung Carcinoma Using RNA-Stabilized Tissue. Journal of Molecular Diagnostics. 17(4). 438–445. 9 indexed citations
5.
Gourley, Charlie, Timothy Perren, James Paul, et al.. (2014). Molecular subgroup of high-grade serous ovarian cancer (HGSOC) as a predictor of outcome following bevacizumab.. Journal of Clinical Oncology. 32(15_suppl). 5502–5502. 76 indexed citations
6.
Gourley, Charlie, Caroline O. Michie, Katherine E. Keating, et al.. (2011). Establishing a molecular taxonomy for epithelial ovarian cancer (EOC) from 363 formalin-fixed paraffin embedded (FFPE) specimens.. Journal of Clinical Oncology. 29(15_suppl). 5000–5000. 5 indexed citations
7.
Kozlov, Sergei, Nuri Gueven, Katherine E. Keating, Jonathan Ramsay, & Martin F. Lavin. (2003). ATP Activates Ataxia-Telangiectasia Mutated (ATM) in Vitro. Journal of Biological Chemistry. 278(11). 9309–9317. 81 indexed citations
8.
Gueven, Nuri, Katherine E. Keating, Philip Chen, et al.. (2001). Epidermal Growth Factor Sensitizes Cells to Ionizing Radiation by Down-regulating Protein Mutated in Ataxia-Telangiectasia. Journal of Biological Chemistry. 276(12). 8884–8891. 44 indexed citations
9.
Keating, Katherine E., Nuri Gueven, Dianne Watters, H. Peter Rodemann, & Martin F. Lavin. (2001). Transcriptional downregulation of ATM by EGF is defective in ataxia-telangiectasia cells expressing mutant protein. Oncogene. 20(32). 4281–4290. 19 indexed citations
10.
Fang, Zhi, John H. Kearsley, Dédée F. Murrell, et al.. (2001). Rapid radiation-induction of ATM protein levels in situ. Pathology. 33(1). 30–36. 16 indexed citations
11.
Fang, Zhi, Maria Sarris, John H. Kearsley, et al.. (2001). RAPID RADIATION-INDUCTION OF ATM PROTEIN LEVELS IN SITU. Pathology. 33(1). 30–36. 10 indexed citations
12.
Lavin, Martin F., Dianne Watters, Kevin J. Spring, et al.. (2000). Sensing damage in DNA: ATM and cellular signalling. Queensland's institutional digital repository (The University of Queensland). 348–351. 1 indexed citations
13.
Khanna, Kum Kum, Katherine E. Keating, Sergei Kozlov, et al.. (1998). ATM associates with and phosphorylates p53: mapping the region of interaction. Nature Genetics. 20(4). 398–400. 391 indexed citations
14.
Quane, Kathleen A., Helle Ørding, Katherine E. Keating, et al.. (1997). Detection of a novel mutation at amino acid position 614 in the ryanodine receptor in malignant hyperthermia. British Journal of Anaesthesia. 79(3). 332–337. 36 indexed citations
15.
Clayton, Linda K., et al.. (1996). CD45 monoclonal antibodies inhibit TCR-mediated calcium signals, calmodulin-kinase IV/Gr activation, and oncoprotein 18 phosphorylation. The Journal of Immunology. 157(1). 101–109. 7 indexed citations
16.
Quane, Kathleen A., et al.. (1996). Diagnosis of malignant hyperthermia: a comparison of the in vitro contracture test with the molecular genetic diagnosis in a large pedigree.. Journal of Medical Genetics. 33(1). 18–24. 8 indexed citations
17.
Keating, Katherine E., Kathleen A. Quane, Bernadette M. Manning, et al.. (1994). Detection of a novel RYR1 mutation in four malignant hyperthermia pedigrees. Human Molecular Genetics. 3(10). 1855–1858. 63 indexed citations
18.
Quane, Kathleen A., Katherine E. Keating, Bernadette M. Manning, et al.. (1994). Detection of a novel common mutation in the ryanodine receptor gene in malignant hyperthermia: implications for diagnosis and heterogeneity studies. Human Molecular Genetics. 3(3). 471–476. 89 indexed citations
19.
Quane, Kathleen A., Katherine E. Keating, Jasmine Healy, et al.. (1994). Mutation Screening of the RYR1 Gene in Malignant Hyperthermia: Detection of a Novel Tyr to Ser Mutation in a Pedigree with Associated Central Cores. Genomics. 23(1). 236–239. 79 indexed citations
20.
Quane, Kathleen A., Jasmine Healy, Katherine E. Keating, et al.. (1993). Mutations in the ryanodine receptor gene in central core disease and malignant hyperthermia. Nature Genetics. 5(1). 51–55. 271 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026